image
Albemarle Corporation ALB
Basic Materials - Chemicals - Specialty - NYSE - US
Watchlist
$ 67.21
-1.15 %
$ 7.91 B
Market Cap
-6.04
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Jul, 6, 2025.

The intrinsic value of one ALB stock under the worst case scenario is HIDDEN Compared to the current market price of 67.2 USD, Albemarle Corporation is HIDDEN

ALB Intrinsic Value
HIDDEN
SHOW

This DCF valuation model was last updated on Jul, 6, 2025.

The intrinsic value of one ALB stock under the base case scenario is HIDDEN Compared to the current market price of 67.2 USD, Albemarle Corporation is HIDDEN

ALB Intrinsic Value
HIDDEN
SHOW

This DCF valuation model was last updated on Jul, 6, 2025.

The intrinsic value of one ALB stock under the best case scenario is HIDDEN Compared to the current market price of 67.2 USD, Albemarle Corporation is HIDDEN

ALB Intrinsic Value
HIDDEN
SHOW
2. FUNDAMENTAL ANALYSIS

Price Chart ALB

image
1M 19%
6M -39%
1Y -34%
3Y -217%
5Y -23%
All
$100.0$100.0$95.0$95.0$90.0$90.0$85.0$85.0$80.0$80.0$75.0$75.0$70.0$70.0$65.0$65.0$60.0$60.0$55.0$55.0$50.0$50.015 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '2515 Apr15 AprMay '25May '2515 May15 MayJun '25Jun '2515 Jun15 JunJul '25Jul '25
FINANCIALS
5.38 B REVENUE
-44.08%
Growth Rates
1Year -44.08%
3Years 17.35%
5Years 8.42%
7Years 8.33%
10Years 8.20%
-1.78 B OPERATING INCOME
-705.31%
Growth Rates
1Year -705.31%
3Years -160.17%
5Years -29.68%
7Years -22.00%
10Years -22.40%
-1.14 B NET INCOME
-72.16%
Growth Rates
1Year -72.16%
3Years -88.32%
5Years -23.55%
7Years -43.31%
10Years -23.20%
702 M OPERATING CASH FLOW
-47.03%
Growth Rates
1Year -47.03%
3Years 26.81%
5Years -0.49%
7Years 12.70%
10Years 3.61%
-1.57 B INVESTING CASH FLOW
43.39%
Growth Rates
1Year 43.39%
3Years -33.17%
5Years 1.10%
7Years -23.57%
10Years -42.33%
1.24 B FINANCING CASH FLOW
99.02%
Growth Rates
1Year 99.02%
3Years 191.34%
5Years 3.56%
7Years 17.77%
10Years -2.56%
1.08 B REVENUE
-12.57%
Growth Rates
1Year -44.08%
3Years 17.35%
5Years 8.42%
7Years 8.33%
10Years 8.20%
19.8 M OPERATING INCOME
348.91%
Growth Rates
1Year -705.31%
3Years -160.17%
5Years -29.68%
7Years -22.00%
10Years -22.40%
49.3 M NET INCOME
-42.08%
Growth Rates
1Year -72.16%
3Years -88.32%
5Years -23.55%
7Years -43.31%
10Years -23.20%
545 M OPERATING CASH FLOW
80817.36%
Growth Rates
1Year -47.03%
3Years 26.81%
5Years -0.49%
7Years 12.70%
10Years 3.61%
-179 M INVESTING CASH FLOW
45.30%
Growth Rates
1Year 43.39%
3Years -33.17%
5Years 1.10%
7Years -23.57%
10Years -42.33%
-120 M FINANCING CASH FLOW
-29.20%
Growth Rates
1Year 99.02%
3Years 191.34%
5Years 3.56%
7Years 17.77%
10Years -2.56%
Balance Sheet Albemarle Corporation
image
Current Assets 3.84 B
Cash & Short-Term Investments 1.19 B
Receivables 1.07 B
Other Current Assets 1.58 B
Non-Current Assets 12.8 B
Long-Term Investments 1.12 B
PP&E 9.45 B
Other Non-Current Assets 2.2 B
7.18 %6.42 %9.54 %6.73 %56.90 %13.24 %Total Assets$16.6b
Current Liabilities 1.97 B
Accounts Payable 944 M
Short-Term Debt 398 M
Other Current Liabilities 625 M
Non-Current Liabilities 4.44 B
Long-Term Debt 3.22 B
Other Non-Current Liabilities 1.23 B
14.73 %6.21 %9.74 %50.20 %19.12 %Total Liabilities$6.4b
EFFICIENCY
Earnings Waterfall Albemarle Corporation
image
Revenue 5.38 B
Cost Of Revenue 5.31 B
Gross Profit 62.5 M
Operating Expenses 1.84 B
Operating Income -1.78 B
Other Expenses -641 M
Net Income -1.14 B
6b6b5b5b4b4b3b3b2b2b1b1b00(1b)(1b)(2b)(2b)5b(5b)63m(2b)(2b)641m(1b)RevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
1.16% GROSS MARGIN
1.16%
Averages
1Year 1.16%
3Years 18.50%
5Years 23.46%
7Years 26.91%
10Years 29.36%
-33.04% OPERATING MARGIN
-33.04%
Averages
1Year -33.04%
3Years 1.11%
5Years 3.29%
7Years 8.86%
10Years 11.47%
-21.93% NET MARGIN
-21.93%
Averages
1Year -21.93%
3Years 7.45%
5Years 7.61%
7Years 10.50%
10Years 10.85%
-11.84% ROE
-11.84%
Averages
1Year -11.84%
3Years 10.16%
5Years 8.29%
7Years 10.63%
10Years 10.31%
-7.10% ROA
-7.10%
Averages
1Year -7.10%
3Years 4.91%
5Years 3.89%
7Years 4.86%
10Years 4.61%
-12.39% ROIC
-12.39%
Averages
1Year -12.39%
3Years 0.88%
5Years 1.28%
7Years 3.43%
10Years 3.54%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Albemarle Corporation
image
800m800m600m600m400m400m200m200m00(200m)(200m)(400m)(400m)(600m)(600m)(800m)(800m)(1b)(1b)20162016201720172018201820192019202020202021202120222022202320232024202420252025
Net Income -1.14 B
Depreciation & Amortization 589 M
Capital Expenditures -1.69 B
Stock-Based Compensation 32.1 M
Change in Working Capital 0
Others 1.55 B
Free Cash Flow -984 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Albemarle Corporation
image
Wall Street analysts predict an average 1-year price target for ALB of $103 , with forecasts ranging from a low of $68 to a high of $150 .
ALB Lowest Price Target Wall Street Target
68 USD 1.18%
ALB Average Price Target Wall Street Target
103 USD 53.66%
ALB Highest Price Target Wall Street Target
150 USD 123.18%
Price
Max Price Target
Min Price Target
Average Price Target
15015014014013013012012011011010010090908080707060605050Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26Jun '26Jun '26Jul '26Jul '26
4. DIVIDEND ANALYSIS
1.05% DIVIDEND YIELD
0.405 USD DIVIDEND PER SHARE
Q1
Q2
Q3
Q4
1.80001.80001.60001.60001.40001.40001.20001.20001.00001.00000.80000.80000.60000.60000.40000.40000.20000.20000.00000.00000.290.3050.320.3350.36750.3850.390.3950.40.40.4050.290.3050.320.3350.36750.3850.390.3950.40.40.4050.290.3050.320.3350.36750.3850.390.3950.40.4050.291.160.3051.220.321.280.3351.340.36751.470.3851.540.391.560.3951.580.41.600.4051.610.812015201520162016201720172018201820192019202020202021202120222022202320232024202420252025
Download SVG
Download PNG
Download CSV
5. COMPETITION
slide 2 of 7
6. Ownership
Insider Ownership Albemarle Corporation
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
368 K USD 2
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
Albemarle (ALB) Stock Drops Despite Market Gains: Important Facts to Note In the most recent trading session, Albemarle (ALB) closed at $67.21, indicating a -1.15% shift from the previous trading day. zacks.com - 2 weeks ago
Why Investors Need to Take Advantage of These 2 Basic Materials Stocks Now The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now. zacks.com - 2 weeks ago
Best Dividend Aristocrats For July 2025 Dividend Aristocrats have underperformed the S&P 500 in 2025, with NOBL up 1.77% versus SPY's 5.55% year-to-date gain. Dividend growth remains healthy, with 44 out of 69 Aristocrats already raising payouts in 2025 and an average growth rate of 4.86%. I identified 21 Aristocrats as both potentially undervalued and offering a projected long-term annualized return of at least 10%. seekingalpha.com - 3 weeks ago
Albemarle (ALB) Exceeds Market Returns: Some Facts to Consider Albemarle (ALB) concluded the recent trading session at $64.95, signifying a +1.88% move from its prior day's close. zacks.com - 3 weeks ago
Investors Heavily Search Albemarle Corporation (ALB): Here is What You Need to Know Albemarle (ALB) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects. zacks.com - 3 weeks ago
69 June Aristocrats: 1 To Buy Five of the ten lowest-priced S&P 500 Dividend Aristocrats are currently attractive buys, offering high yields and fair valuations for income investors. Analyst forecasts suggest potential net gains of 15.65% to 36.53% for the top ten Aristocrat Dogs by June 2026, with average risk below the market. Fifteen Aristocrats show negative free cash flow margins, signaling caution—dividends may not be sustainable for these cash-poor stocks. seekingalpha.com - 1 month ago
Albemarle's Lithium Reset: Strong Buy Amid Cyclical Downturn And Structural Rebirth We Initiate Albemarle at Strong Buy, $125 PT, citing deep undervaluation and robust volume growth from project ramps and cost discipline. ALB's volume-led strategy, contract coverage, and supply chain optimization position it for margin outperformance even in a flat lithium price environment. Disciplined capital allocation and cost savings drive strong cash conversion and liquidity, supporting free cash flow breakeven in FY25. seekingalpha.com - 1 month ago
3 Growth Stocks Too Small for Institutions to Buy Most retail investors fall to the default belief that they do not have any competitive advantage compared to the world of hedge funds and investment banks, otherwise known as the smart money institutional players on Wall Street. While this is mostly true across the board, access to information, leverage of connections, and industry insights are not the only factors that can help retail investors get ahead every single time. marketbeat.com - 1 month ago
Albemarle: This Minerals Stock Could Make A Good Portfolio Addition Albemarle's stock performance is closely tied to lithium prices, with EV demand and alternative minerals influencing future prospects. The company's financials show solid revenue and cost management, but profitability is highly sensitive to lithium price fluctuations. Valuation metrics suggest Albemarle is undervalued if lithium prices recover, though technical analysis indicates potential for further downside. seekingalpha.com - 1 month ago
Albemarle Corporation to Release Second Quarter 2025 Earnings Results on Wednesday, July 30, 2025 CHARLOTTE, North Carolina, June 18, 2025 /PRNewswire/ -- Albemarle Corporation (NYSE: ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, announced today that it will release its second quarter 2025 earnings after the NYSE closes on Wednesday, July 30, 2025. The company will hold a conference call to discuss its second quarter 2025 results on Thursday, July 31, at 8 a.m. prnewswire.com - 1 month ago
3 Diversified Chemical Stocks to Watch Amid Demand Headwinds Soft demand in specific markets and the sluggishness in China and Europe pose headwinds for the Zacks Chemicals Diversified industry. DD, ALB and KRO are poised to navigate the industry challenges. zacks.com - 1 month ago
Albemarle (ALB) Increases Despite Market Slip: Here's What You Need to Know In the most recent trading session, Albemarle (ALB) closed at $65.08, indicating a +1.37% shift from the previous trading day. zacks.com - 1 month ago
8. Profile Summary

Albemarle Corporation ALB

image
COUNTRY US
INDUSTRY Chemicals - Specialty
MARKET CAP $ 7.91 B
Dividend Yield 1.05%
Description Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and lithium aluminum hydride for use in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes in the areas of steroid chemistry and vitamins, life sciences, pharmaceutical industry, and other markets. It also provides cesium products for the chemical and pharmaceutical industries; zirconium, barium, and titanium products for pyrotechnical applications that include airbag initiators; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services. The Bromine segment offers bromine and bromine-based fire safety solutions; specialty chemicals, including elemental bromine, alkyl and inorganic bromides, brominated powdered activated carbon, and other bromine fine chemicals for use in chemical synthesis, oil and gas well drilling and completion fluids, mercury control, water purification, beef and poultry processing, and other industrial applications; and other specialty chemicals, such as tertiary amines for surfactants, biocides, and disinfectants and sanitizers. The Catalysts segment provides hydroprocessing, isomerization, and akylation catalysts; fluidized catalytic cracking catalysts and additives; and organometallics and curatives. The company serves the energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, and crop protection markets. Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina.
Contact 4250 Congress Street, Charlotte, NC, 28209 https://www.albemarle.com
IPO Date Feb. 22, 1994
Employees 8300
Officers Mr. Eric W. Norris Executive Vice President & Chief Commercial Officer Ms. Meredith H. Bandy C.F.A. Vice President of Investor Relations & Sustainability Ms. Stacy G. Grant Senior Vice President, General Counsel, Chief Compliance Officer & Corporate Secretary Ms. Cynthia Renee Lima Senior Vice President and Chief External Affairs & Communications Officer Mr. Brian Tessin Chief Tax Counsel & Vice President of Tax Mr. Jerry Kent Masters Jr. Chairman, President & Chief Executive Officer Mr. Netha N. Johnson Jr. Executive Vice President & Chief Operating Officer Ms. Melissa H. Anderson Executive Vice President and Chief People & Transformation Officer Mr. Donald J. LaBauve Jr. Chief Accounting Officer, Vice President, Corporate Controller & Chief Financial Officer of Lithium Global Business Unit Mr. Neal R. Sheorey Executive Vice President & Chief Financial Officer